UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.

A UCSF-led found that people who are experiencing homelessness have a 16-fold higher rate of sudden death from heart attacks, as well as other causes.

UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.

Come with us on a visit to the UCSF Library to look through their extensive Rare Book Archive, which includes some historic and "priceless" materials dating back centuries chronicling the very beginnings of health science and research.

Two sisters are receiving a breakthrough, FDA-approved treatment for beta thalassemia at UCSF Benioff Children's Hospital, Oakland. This is the first real therapy other than monthly transfusions for a devastating disease that destines people to shorter lives.

Being suspended from school or sent to the office is tied to a big drop in grade point average (GPA), especially for Black and Latinx children.

UCSF experts to discuss amyloid therapies and dementia research at CTAD conference, addressing equity, novel treatments, and innovative studies.

A study found that children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab.

The Zena Werb Memorial Lecture in Cancer Biology series is a product of an effort organized by family, colleagues and friends to celebrate the life and work of the late cancer researcher Zena Werb.

UCSF Chancellor Sam Hawgood’s 10th State of the University address will feature a first-ever AI panel discussion with experts Atul Butte, MD, PhD, and Sara Murray, MD, MAS